In last trading session, biote Corp (NASDAQ:BTMD) saw 0.8 million shares changing hands with its beta currently measuring 1.23. Company’s recent per share price level of $3.76 trading at $0.69 or 22.48% at ring of the bell on the day assigns it a market valuation of $204.31M. That closing price of BTMD’s stock is at a discount of -124.47% from its 52-week high price of $8.44 and is indicating a premium of 19.15% from its 52-week low price of $3.04. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.37 million shares which gives us an average trading volume of 164.18K if we extend that period to 3-months.

For biote Corp (BTMD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.19 in the current quarter.

biote Corp (NASDAQ:BTMD) trade information

Upright in the green during last session for gaining 22.48%, in the last five days BTMD remained trading in the red while hitting it’s week-highest on Monday, 03/10/25 when the stock touched $3.76 price level, adding 12.35% to its value on the day. biote Corp’s shares saw a change of -39.16% in year-to-date performance and have moved -11.74% in past 5-day. biote Corp (NASDAQ:BTMD) showed a performance of -19.31% in past 30-days. Number of shares sold short was 0.65 million shares which calculate 3.97 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 8.62 to the stock, which implies a rise of 56.38% to its current value. Analysts have been projecting 8.24 as a low price target for the stock while placing it at a high target of 9. It follows that stock’s current price would drop -119.15% in reaching the projected high whereas dropping to the targeted low would mean a loss of -119.15% for stock’s current value.

biote Corp (BTMD) estimates and forecasts

This year revenue growth is estimated to rise 5.48% from the last financial year’s standing.

5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 47.2M for the same. And 5 analysts are in estimates of company making revenue of 50.44M in the next quarter. Company posted 46.8M and 49.17M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -21.77% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 404.44% while estimates for its earnings growth in next 5 years are of 121.27%.

biote Corp (NASDAQ:BTMD)’s Major holders

Insiders are in possession of 27.60% of company’s total shares while institution are holding 67.53 percent of that, with stock having share float percentage of 93.27%. Investors also watch the number of corporate investors in a company very closely, which is 67.53% institutions for biote Corp that are currently holding shares of the company. 325 CAPITAL LLC is the top institutional holder at BTMD for having 3.77 million shares of worth $28.14 million. And as of 2024-06-30, it was holding 11.3892 of the company’s outstanding shares.

The second largest institutional holder is BANDERA PARTNERS LLC, which was holding about 2.44 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.3646 of outstanding shares, having a total worth of $18.19 million.

On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 850.43 shares of worth $3.2 million or 2.68% of the total outstanding shares. The later fund manager was in possession of 706.69 shares on Dec 31, 2024 , making its stake of worth around $2.66 million in the company or a holder of 2.23% of company’s stock.